Premium
Comparative analysis of AP‐2α and AP‐2β gene expression during murine embryogenesis
Author(s) -
Moser Markus,
Rüschoff Josef,
Buettner Reinhard
Publication year - 1997
Publication title -
developmental dynamics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.634
H-Index - 141
eISSN - 1097-0177
pISSN - 1058-8388
DOI - 10.1002/(sici)1097-0177(199701)208:1<115::aid-aja11>3.0.co;2-5
Subject(s) - biology , mesenchyme , in situ hybridization , neural tube , neural crest , embryogenesis , gene expression , embryonic stem cell , embryo , microbiology and biotechnology , gene , genetics
Abstract Transcription factor AP‐2 has been identified as playing important roles during embryonic development of the neural tube, neural crest derivatives, skin, and urogenital tissues. Recently, we isolated a second AP‐2 transcription factor, AP‐2β, which is 76% homologous to the previously known AP‐2α gene, and showed that both genes are coexpressed in murine embryos at day 13.5 and 15.5 post coitum (pc). In the current study, we used specific cRNA probes to study comparatively AP‐2α and AP‐2β expression by in situ hybridization of murine embryonic tissue sections. Our results reveal that expression of both genes starts at day 8 pc in the lateral head mesenchyme and extraembryonic trophoblast. The expression pattern was identical until day 10 pc but diverged significantly during later stages of development. From day 11 forward, specific expression patterns of AP‐2α and AP‐2β mRNA were observed. Specific AP‐2β signals were detected in the midbrain, sympathetic ganglia, adrenal medulla, and cornea. Specific AP‐2β signals were present in the limb buds, dorsal root ganglia, tooth germs, and Moll's and Meibom's glands. In contrast, expression of both genes occured in skin, facial mesenchyme, spinal cord, cerebellum, and renal tubular epithelia. Our results indicate that both genes are expressed with different temporal and spatial patterns during embryonic development. Dev Dyn 208:115–124, 1997. © 1997 Wiley‐Liss, Inc.